Phenoxybenzamine hydrochloride

SIGMA/B019 - ≥97%, powder

Synonym: N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine hydrochloride

CAS Number: 63-92-3
Empirical Formula (Hill Notation): C₁₈H₂₂ClNO · HCl
Molecular Weight: 340.29
EC Number: 200-569-7
MDL Number: MFCD00055152
Linear Formula: C₁₈H₂₂ClNO · HCl
Product Type: Chemical

Catalog Number	PKG Qty.	Price


45-B019-250MG	250 mg	$137.00 1/EA	Add To Favorites

This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: B019-250MG

Properties
Descriptions
Safety Info.
Basic Data

assay	≥97%
color	white
form	powder
InChI	1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H
InChI key	VBCPVIWPDJVHAN-UHFFFAOYSA-N
originator	Wellspring
Quality Level	100
SMILES string	Cl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2
solubility	alcohol: soluble
	H₂O: slightly soluble
	propylene glycol: soluble
storage temp.	2-8°C

Biochem/physiol Actions:	Calmodulin antagonist; α-adrenoceptor antagonist.
Features and Benefits:	This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm .
Features and Benefits:	This compound was developed by Wellspring . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here .
Packaging:	250 mg in glass bottle

Symbol	GHS07,GHS08
Signal word	Warning
Hazard statements	H302 - H351
Precautionary statements	P201 - P301 + P312 + P330 - P308 + P313
Hazard Codes	Xn
Risk Statements	22-40
Safety Statements	22-36/37/39-45
RIDADR	NONH for all modes of transport
WGK Germany	WGK 3
Flash Point(F)	Not applicable
Flash Point(C)	Not applicable

Purity	≥97%
Storage Temp.	2-8°C
UNSPSC	12352116

To Order From a Quote